BIO-key International Inc. (NASDAQ:BKYI) Shares Shorted: Short Interest Up 14,917.0% in September

BIO-key International Inc. (NASDAQ:BKYI) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 995,329 shares, an increase of 14,917.0% from the September 15th total of 6,628 shares. Based on an average daily volume of 15,350,267 shares, the days-to-cover ratio is currently 0.1 days. Currently, 72.2% of the shares of the stock are sold short.

BIO-key International Stock Down 4.0%

Shares of BIO-key International stock traded down $0.07 on Friday, hitting $1.67. The company’s stock had a trading volume of 79,324 shares, compared to its average volume of 1,039,427. BIO-key International has a 52-week low of $1.61 and a 52-week high of $19.70. The firm has a fifty day moving average price of $2.91 and a 200-day moving average price of $4.20. The company has a market capitalization of $2.40 million, a P/E ratio of -0.41 and a beta of 0.50.

BIO-key International (NASDAQ:BKYI) last posted its earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.26. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. As a group, analysts expect that BIO-key International will post -1.62 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Zacks Research upgraded shares of BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce”.

BIO-key International Company Profile

BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.

The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.

BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.